OHRP
OHR Pharmaceutical Inc

7,881
Loading...
Loading...
NeuBase Therapeutics, Inc. engages in the development of drugs for patients with genetic neurological disorder. Its pipelines include Huntington's Disease, NT0100 Program - PATrOL Enabled gamma-PNA for Huntington's Disease, and NT0200 Program- PATrOL Enabled gamma-PNA for Myotonic Dystophy. The company was founded by Dietrich A. Stephan on August 28, 2018 and is headquartered in Pittsburgh, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3

Frequently Asked Questions

What is Market Cap of NeuBase Therapeutics Inc?
What is the 52-week high for NeuBase Therapeutics Inc?
What is the 52-week low for NeuBase Therapeutics Inc?
What is NeuBase Therapeutics Inc stock price today?
What was NeuBase Therapeutics Inc stock price yesterday?
What is the PE ratio of NeuBase Therapeutics Inc?
What is the Price-to-Book ratio of NeuBase Therapeutics Inc?
What is NeuBase Therapeutics Inc's EBITDA?
What is the 50-day moving average of NeuBase Therapeutics Inc?
How many employess does NeuBase Therapeutics Inc has?

Latest OHRP News

View
No OHRP news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.